Business · 22/10/20261 min read

The results of the crash test demonstrate Cherys commitment to family safety.

Summary

WUHU, China, October 22, 2026 — On October 22, 2026, CHERY held the CHERRY Brand Safety Challenge at Longshan Crash Laboratory in Wuhu under the theme "Guardian. For Family". Global media, automotive opinion...

Original source language: PR Newswire — Global News ReleasesOpen original release →

Add your company to Business Communicator

We monitor business sources and connect attention with companies, profiles and services available in Business Communicator.

Create a free company profile Explore businesses on Business Maps →

Create a free company profile →

Explore insights

Business insights →

Global Markets News Trade Regulation News Business Technology News Fintech for Business: Payments & Banking News Supply Chain News Central Bank Policy News

Related business signals

Business · 10/22/2026

The results of the crash test demonstrate CHERY's commitment to family safety.

WUHU, China, Oct. 23, 2026 — On October 22, 2026, CHERY held the CHERRY Brand Safety Challenge at Longshan Crash Laboratory in Wuhu under the theme "Guardian. For Family". Global media, automotive opinion...

Read summary →

Business · 10/22/2026

Bulletin from Sivers Semiconductors AB's Extraordinary General Meeting on 22 October 2026

KISTA, Sweden, Oct. 22, 2026 — The Extraordinary General Meeting in Sivers Semiconductors AB (the "Company") was held on October 22, 2026, and in particular the following resolutions were resolved. Election...

Read summary →

Business · 10/23/2026

Primis Financial Corp. reports strong results for the third quarter of 2026

Declares Quarterly Cash Dividend of $0.10 Per Share MCLEAN, Va., Oct. 22, 2026 — Primis Financial Corp. (NASDAQ: FRST) ("Primis" or the "Company"), and its wholly owned subsidiary, Primis Bank (the "Bank...

Read summary →

Business · 10/23/2026

Harbour BioMed receives China NMPA approval for Batoclimab injection (subcutaneous injection) for the treatment of generalized myasthenia gravis

The first NMPA-approved anti-FcRn therapy to complete its full clinical development for gMG patients in China CAMBRIDGE, Mass. , ROTTERDAM, Netherlands and SHANGHAI, Oct. 22, 2026 — Harbour BioMed (the "C...

Read summary →

Business · 10/23/2026

Seatrium and Karpowership sign contract for a series of whale class power conversion and integration projects

SINGAPORE, 23 October 2026 — Seatrium Limited and its strategic partner, floating power leader Karpowership, have strengthened their longstanding collaboration with the award of a contract for the development...

Read summary →

Business · 10/23/2026

ImmVira presents clinical data from three bladder cancer studies at ESMO 2026

SUZHOU, China, Oct. 22, 2026 — ImmVira Group ("ImmVira") today announced that updated clinical data from three bladder cancer studies of its leading oncolytic immunotherapy candidate, MVR-T3011, will be pre...

Read summary →